Newsletter
SEMPRE: Pricing, Access, and Affordability, Disrupting the Generics Market with Satish Srinivasan, Founder and CEO of DiRx

Outcomes Rocket

SEMPRE: Pricing, Access, and Affordability, Disrupting the Generics Market with Satish Srinivasan, Founder and CEO of DiRx

October 5, 2022

SEMPRE: Pricing, Access, and Affordability, Disrupting the Generics Market with Satish Srinivasan, Founder and CEO of DiRx

If the prices of generics go down, more people will be able to buy them, leading to better health outcomes across the nation.

In this episode of Sempre Health, we have Satish Srinivasan, founder, and CEO of DiRx, talking about the company’s innovative system to increase medication access to the population. He is changing the game by eliminating the middlemen between consumers and manufacturers. The company, founded in the midst of the pandemic, is lowering costs by buying directly from the source and delivering to the patients. DiRx is now offering several plans, like a year-long one, for unlimited prescriptions and refills, something no provider had done before. Satish also shared the challenges they have faced, and where he sees the company and the healthcare industry going in the future.

Tune in and listen to how DiRx is disrupting the whole market!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.